Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Buy MGM Stock as Vegas Re-Opens and BetMGM Expands Its Market

With its sports-betting joint venture surging and Las Vegas rebounding, MGM stock remains a very good bet at its current levels.

Iterum Therapeutics Stock Looks Like a High-Risk Name Here

The fact that other antibiotic makers have declared bankruptcy in recent years is a negative sign for Iterum. Long-term investors should avoid ITRM stock.

Bumble’s Strong Results, Initiatives Bode Very Well for BMBL Stock

After Bumble reported very strong Q4 results and described its initiatives, the longer-term outlook of BMBL stock remains very strong.

Sea Limited Stock Has Huge Potential, but Wait for the Pullback

SE stock has a very bright longer-term future, as Sea's growth and geographic region are strong. But the shares' shorter-term outlook is negative.

Hold Onto Plug Power Stock, But Don’t Buy More Yet

Although investors should stay away from PLUG stock for now, the shares could easily become attractive in the near term.

Long-Term Investors Should Buy a Small Amount of Nio Stock on Weakness

At this point, BlackBerry is much more attractive than Nio stock for long-term investors

4 Overvalued Stocks to Leave Out of a Portfolio

Disney, Fisker, Lordstown and Virgin Galactic all have overvalued stocks because their risk levels and valuations are far too elevated.

Tattooed Chef Stock Looks Better Than It Did, but It’s Still Overvalued

Tattoo Chef is making the right moves, and TTCF stock has become more appetizing. But the shares aren't a buy yet.

Sell Ocugen Stock Now Before It Sinks Even Further

Biden's decision to buy 100 million more of Johnson & Johnson's vaccine, along with the potential of herd immunity, makes OCGN stock a sell.

Addressable Market Aside, Bionano Stock Is a Buy on Innovation Alone

Bionano's Saphyr system looks poised to revolutionize diagnostics and medical research, making BNGO stock worth buying for long-term investors.